Centaurus Financial’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.13M | Sell |
3,213
-79
| -2% | -$28.2K | 0.05% | 310 |
|
|
2025
Q4 | $1.08M | Buy |
3,292
+1,662
| +102% | +$527K | 0.05% | 325 |
|
|
2025
Q3 | $460K | Buy |
1,630
+648
| +66% | +$188K | 0.02% | 558 |
|
|
2025
Q2 | $274K | Sell |
982
-1,263
| -56% | -$358K | 0.02% | 636 |
|
|
2025
Q1 | $700K | Buy |
2,245
+1,016
| +83% | +$300K | 0.04% | 362 |
|
|
2024
Q4 | $320K | Sell |
1,229
-139
| -10% | -$41.2K | 0.02% | 546 |
|
|
2024
Q3 | $441K | Sell |
1,368
-247
| -15% | -$80.8K | 0.03% | 435 |
|
|
2024
Q2 | $505K | Buy |
1,615
+232
| +17% | +$68.2K | 0.03% | 384 |
|
|
2024
Q1 | $393K | Buy |
1,383
+481
| +53% | +$141K | 0.03% | 436 |
|
|
2023
Q4 | $260K | Sell |
902
-316
| -26% | -$86.1K | 0.02% | 518 |
|
|
2023
Q3 | $327K | Buy |
1,218
+142
| +13% | +$35.4K | 0.03% | 443 |
|
|
2023
Q2 | $239K | Sell |
1,076
-1,855
| -63% | -$430K | 0.02% | 517 |
|
|
2023
Q1 | $709K | Buy |
2,931
+525
| +22% | +$129K | 0.06% | 316 |
|
|
2022
Q4 | $632K | Buy |
2,406
+278
| +13% | +$74.5K | 0.06% | 314 |
|
|
2022
Q3 | $480K | Buy |
2,128
+189
| +10% | +$45.8K | 0.05% | 356 |
|
|
2022
Q2 | $472K | Sell |
1,939
-335
| -15% | -$82.1K | 0.05% | 381 |
|
|
2022
Q1 | $550K | Sell |
2,274
-1,173
| -34% | -$270K | 0.04% | 406 |
|
|
2021
Q4 | $776K | Buy |
3,447
+143
| +4% | +$30.2K | 0.06% | 328 |
|
|
2021
Q3 | $703K | Buy |
3,304
+296
| +10% | +$68.1K | 0.06% | 339 |
|
|
2021
Q2 | $733K | Sell |
3,008
-120
| -4% | -$29.5K | 0.06% | 332 |
|
|
2021
Q1 | $778K | Sell |
3,128
-161
| -5% | -$38.4K | 0.08% | 284 |
|
|
2020
Q4 | $756K | Sell |
3,289
-84
| -2% | -$19.4K | 0.08% | 282 |
|
|
2020
Q3 | $857K | Buy |
3,373
+2,353
| +231% | +$583K | 0.12% | 189 |
|
|
2020
Q2 | $241K | Sell |
1,020
-10
| -1% | -$2.28K | 0.04% | 377 |
|
|
2020
Q1 | $209K | Sell |
1,030
-314
| -23% | -$68.6K | 0.04% | 329 |
|
|
2019
Q4 | $324K | Sell |
1,344
-191
| -12% | -$42.1K | 0.05% | 369 |
|
|
2019
Q3 | $297K | Sell |
1,535
-856
| -36% | -$164K | 0.05% | 349 |
|
|
2019
Q2 | $441K | Buy |
2,391
+1,955
| +448% | +$350K | 0.07% | 289 |
|
|
2019
Q1 | $2.29K | Buy |
436
+141
| +48% | +$26.9K | 0.01% | 463 |
|
|
2018
Q4 | $2 | Buy |
295
+294
| +29,400% | +$57.4K | 0.01% | 387 |
|
|
2018
Q3 | $302 | Sell |
1
-5,680
| -100% | -$1.12M | 0.05% | 308 |
|
|
2018
Q2 | $1.05M | Buy |
5,681
+4,277
| +305% | +$757K | 0.14% | 157 |
|
|
2018
Q1 | $239K | Buy |
+1,404
| New | +$258K | 0.06% | 297 |
|
Other funds holding AMGN
VCM
VPM
Centaurus Financial's AMGN Position: Q1 2026 in Review
Centaurus Financial reduced its Amgen (AMGN) stake by 2.4% in Q1 2026, selling an estimated $28.2K and leaving 3,213 shares worth $1.13M. The position accounts for 0.05% of the portfolio, ranked #310.
Centaurus Financial first reported a position in AMGN in Q1 2018 and has held it in 33 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Centaurus Financial held 3,213 shares of Amgen worth $1.13M as of Q1 2026.
- Centaurus Financial sold 79 Amgen shares in Q1 2026, an estimated $28.2K.
- Amgen made up 0.05% of Centaurus Financial's portfolio in Q1 2026, its #310 holding.
- Centaurus Financial first reported a position in Amgen in Q1 2018 and has held it in 33 quarters since.
- 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Centaurus Financial's 13F filing for Q1 2026, filed 18 May 2026.